Abiopharma

Director Valantine Hannah 🟡 adjusted position in 8.7K shares (1 derivative) of BridgeBio Pharma, Inc. (BBIO) at $72.00 ($1.1M) Transaction Date: Mar 10, 2026 | Filing ID: 000260

Poole Ahn Amanda 🟡 adjusted position in 33.8K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002

📋 Mountcastle David (Officer) plans to sell 6K shares of Privia Health Group, Inc. (at $21.90 each, total $141K) Filed: Mar 12, 2026 | ID: 002259

Elkins David V 🟡 adjusted position in 47.0K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002

📋 Rodman David Malcom (Officer) plans to sell 6K shares of Mineralys Therapeutics, Inc. (at $27.37 each, total $174K) Filed: Mar 12, 2026 | ID: 000171

McDonald Colin Patrick 🔴 sold 6.2K shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $9.70 Transaction Date: Mar 11, 2026 | Filing ID: 000243

(30% Negative) LYELL IMMUNOPHARMA, INC. (LYEL) Reports Q1 2026 Financial Results

LeBlanc Dorian Paul 🟡 adjusted position in 96 shares (1 derivative) of LEMAITRE VASCULAR INC (LMAT) at $109.20 Transaction Date: Mar 10, 2026 | Filing ID: 104162

(10% Negative) VAXART, INC. (VXRT) Reports Q1 2026 Financial Results

(99% Neutral) OIL-DRI CORPORATION OF AMERICA (ODC) Reports Q1 2026 Financial Results